Faeth Therapeutics, Inc.
FTHNasdaqCIK 1829802HealthcareFiscal year ends Dec 31
Reports and events: 128 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-0916:31 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-057106 |
| 2024-05-0907:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-134767 |
| 2024-04-2916:30 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0000950170-24-049938 |
| 2024-04-1216:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-094756 |
| 2024-04-0207:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-084096 |
| 2024-03-0718:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-009294 |
| 2024-03-0516:44 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-24-059356 |
| 2024-02-2916:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023148 |
| 2024-02-2807:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-049197 |
| 2024-02-1317:34 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-006231 |
| 2024-02-0816:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-24-028396 |
| 2024-01-0408:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-001950 |
| 2023-11-0716:40 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-060340 |
| 2023-11-0707:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-271921 |
| 2023-11-0606:07 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-23-270798 |
| 2023-11-0317:03 ET | SC 13D | Ownership report, active investor | 0000921895-23-002454 |
| 2023-11-0316:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-270377 |
| 2023-10-2017:01 ET | 8-K | 3.01 Delisting notice | 0001193125-23-259994 |
| 2023-08-0316:32 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-038085 |
| 2023-08-0308:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-202349 |
| 2023-07-1016:31 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-184650 |
| 2023-06-2709:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-175647 |
| 2023-06-2316:30 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-23-173860 |
| 2023-06-1516:31 ET | DEF 14A | Proxy statementPeriod 2023-07-10 | 0000950170-23-028311 |
| 2023-06-0217:00 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-23-001419 |
| 2023-05-2316:50 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-23-001333 |
| 2023-05-2316:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-151834 |
| 2023-05-0916:32 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019754 |
| 2023-05-0908:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-138934 |
| 2023-05-0116:18 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0000950170-23-016251 |
| 2023-04-2008:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-107449 |
| 2023-03-2907:31 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-010432 |
| 2023-03-2808:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-081485 |
| 2023-03-1307:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-068480 |
| 2023-03-1009:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-066980 |
| 2023-03-0917:15 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-23-000671 |
| 2023-03-0717:30 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-063316 |
| 2023-02-0607:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-024891 |
| 2022-12-0916:31 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-22-301836 |
| 2022-12-0808:18 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-300545 |
| 2022-11-2106:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-22-001584 |
| 2022-11-1009:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-282053 |
| 2022-11-0816:32 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-023276 |
| 2022-11-0808:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-279720 |
| 2022-11-0211:58 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-22-002887 |
| 2022-09-3016:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-255560 |
| 2022-08-3107:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-234612 |
| 2022-08-0917:00 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016148 |
| 2022-08-0907:46 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-215634 |
| 2022-07-1917:30 ET | SC 13D | Ownership report, active investor | 0001193805-22-001110 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 3, 2026, 23:17 ET. Listed shows no prices and gives no investment advice.